These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8452815)

  • 1. Bone marrow abnormalities in the non-obese diabetic mouse.
    Langmuir PB; Bridgett MM; Bothwell AL; Crispe IN
    Int Immunol; 1993 Feb; 5(2):169-77. PubMed ID: 8452815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice.
    Steptoe RJ; Ritchie JM; Harrison LC
    J Immunol; 2002 May; 168(10):5032-41. PubMed ID: 11994455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in the differentiation and function of bone marrow-derived dendritic cells in non-obese diabetic mice.
    Lee M; Kim AY; Kang Y
    J Korean Med Sci; 2000 Apr; 15(2):217-23. PubMed ID: 10803701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cells and myeloid precursor cells in nonobese diabetic (NOD) mice.
    Lepault F; Gagnerault MC; Dardenne M; Bach JF
    Int J Cell Cloning; 1992 May; 10(3):173-81. PubMed ID: 1613268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic in vitro abnormalities in dendritic cell generation caused by non-MHC non-obese diabetic genes.
    Prasad SJ; Goodnow CC
    Immunol Cell Biol; 2002 Apr; 80(2):198-206. PubMed ID: 11940121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.
    Boudaly S; Morin J; Berthier R; Marche P; Boitard C
    Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-dendritic cell unbalance in the non-obese diabetic mice.
    Morin J; Chimènes A; Boitard C; Berthier R; Boudaly S
    Cell Immunol; 2003 May; 223(1):13-25. PubMed ID: 12914754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
    Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
    Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M-CSF and GM-CSF regulation of STAT5 activation and DNA binding in myeloid cell differentiation is disrupted in nonobese diabetic mice.
    Rumore-Maton B; Elf J; Belkin N; Stutevoss B; Seydel F; Garrigan E; Litherland SA
    Clin Dev Immunol; 2008; 2008():769795. PubMed ID: 19165346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential patterns of production of granulocyte macrophage colony stimulating factor, IL-2, IL-3 and IL-4 by cultured islets of Langerhans from non-obese diabetic and non-diabetic strains of mice.
    Burlinson EL; Drakes ML; Wood PJ
    Int Immunol; 1995 Jan; 7(1):79-87. PubMed ID: 7718517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse.
    Strid J; Lopes L; Marcinkiewicz J; Petrovska L; Nowak B; Chain BM; Lund T
    Clin Exp Immunol; 2001 Mar; 123(3):375-81. PubMed ID: 11298122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen.
    Sugiura K; Ikehara S; Inaba M; Haraguchi S; Ogata H; Sardiña EE; Sugawara M; Ohta Y; Good RA
    Exp Hematol; 1992 Feb; 20(2):256-63. PubMed ID: 1531958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
    Serreze DV; Gaskins HR; Leiter EH
    J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells.
    Seydel F; Garrigan E; Stutevoss B; Belkin N; Makadia B; Carter J; Shi JD; Davoodi-Semiromi A; McDuffie M; Litherland SA
    J Autoimmun; 2008 Dec; 31(4):377-84. PubMed ID: 18945591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice.
    Simpson PB; Mistry MS; Maki RA; Yang W; Schwarz DA; Johnson EB; Lio FM; Alleva DG
    J Immunol; 2003 Oct; 171(7):3333-7. PubMed ID: 14500624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains.
    Feili-Hariri M; Morel PA
    Clin Immunol; 2001 Jan; 98(1):133-42. PubMed ID: 11141336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.